Liminatus Pharma

Wilmington, United States

Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.

$1.9M raised

Jun 2026

Post-IPO Equity

Advice Biopharma Biotechnology Health Care Management Consulting

Top Investors

Capital Trust Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Liminatus Pharma

How much funding has Liminatus Pharma raised?

Liminatus Pharma has raised $1.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.

Who are Liminatus Pharma's investors?

Liminatus Pharma's investors include Capital Trust Group.

Where is Liminatus Pharma headquartered?

Liminatus Pharma is headquartered in Wilmington, United States.

What does Liminatus Pharma do?

Liminatus Pharma is a immuno‑oncology company offering CD47‑blockade antibody solutions to prevent anemia and thrombocytopenia.

What stage is Liminatus Pharma at?

Liminatus Pharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 3, 2026.

MLA

"Liminatus Pharma — Funding & Investors." VCBacked, June 3, 2026, https://www.vcbacked.co/company/liminatus-pharma. Accessed July 2, 2026.

APA

VCBacked. (2026). Liminatus Pharma — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/liminatus-pharma

Wikipedia (cite web)

{{cite web |title=Liminatus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/liminatus-pharma |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 3, 2026.

Similar Companies in Advice

Burton Property Group

Mobile$82.4M

Spearhead Corporate Development

Toronto$3.2M

Hello Divorce

Alameda

8B Education Investments

New York